Dr Yasir Khan is a strong advocate for clinical trials and local research, ensuring his patients have access to the latest treatment options close to home. He brings a holistic, evidence-based approach to his practice and his patients benefit from his clinical research background and deep understanding of cancer care. His patient-centred approach emphasises clear communication and collaborative decision-making.
Biography
Dr Yasir Khan is a medical oncologist at Icon Cancer Centre Midland. In 2008 he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at the University of Health & Sciences in Lahore, Pakistan before relocating to Western Australia (WA). Dr Khan subsequently commenced specialist oncology training at Sir Charles Gairdner Hospital and Fiona Stanley Hospital in WA. In 2020, he completed a one-year clinical research fellowship in melanoma and kidney cancers at the Royal Marsden Hospital in London. During his fellowship, Dr Khan was the lead clinical research fellow in novel cell therapy clinical trials, collaborating with leading oncologists and researchers on multiple research projects.
Dr Khan has been Head of Oncology at Peel Health Campus since September 2021 and was appointed Head of Medical Specialities in August 2024. He also works at St. John of God (SJOG) Midland Hospital and is an adjunct clinical senior lecturer at Curtin University. He is actively involved in mentoring medical students and junior doctors.
Dr Khan maintains an active interest in clinical trials, medical education and research and has previous experience as a sub-investigator on various clinical trials including autologous tumour-infiltrating lymphocyte and NAR-T cell therapies. He has published several articles and abstracts in peer-reviewed journals and presented at state and national meetings.
Dr Khan is a fellow of the Royal Australasian College of Physicians (FRACP) and a member of several leading Australian and New Zealand cancer trial groups. He has expertise in immunotherapy treatments and novel immunotherapy agents. Dr Yasir Khan treats a broad range of malignancies and has a special interest in novel immunotherapy agents, thoracic cancers, breast cancer, genitourinary cancers, gastrointestinal cancers and melanoma.